Description of the project
MEMOVE is a transdisciplinary proposal that aims at developing new mathematical models, numerical tools as well as new experimental protocols to provide a complete understanding of the electropermeabilization from the cell to the tissue scale. The consortium is composed of four partners with complementary skills:- the INRIA research team MC2, which is the leading partner of MEMOVE,
- the Department of Mathematics of the University of Versailles (LMV),
- the team of Vectorology and Anticancer Therapies at the Institut Gustave Roussy (VAT lab) at Villejuif,
- the bioengineering laboratory Ampère at Lyon.
At the cell scale, it is proposed to develop new electrical cell PDEs models that describe simultaneously the electropermeabilization by micropulses, and the electrophysiological changes of the cell during the process (cell swelling, ions fluxes in the cell...). Moreover a theoretical asymptotic analysis will be performed to study the electropermeabilization of closely touching cells, while homogenization of single cell models will help in the understanding of the electroporation of cell suspension solution. From the experimental point of view, new device manufacturing to simultaneously electroporate vesicles and quantify this electroporation will be performed. These experiments will highlight the specificity of cell electroporation, when compared to the simplest experimental cell model that is liposome.
At the tissue scale, MEMOVE aims at providing a non-linear tissue conductivity modeling, with parameters that will be fitted with the experiments on potatoes, and rat liver, through data assimilation techniques based on proper orthogonal decomposition developed by MC2. Here again, both numerical and experimental influences of the pulse properties on the tissue electroporation will be investigated.
The final goal of the project, once these multiscale models will be derived, is to provide numerical tools that ensure the optimal pulse delivery for a given realistic geometry of tissue, in order to propose a code that could be useful to the physician applying electrochemotherapy as cancer treatment. The full human body meshing developed by Ampère will be useful to perform the robust optimization to ensure the best pulse delivery that will be addressed by Ampère, MC2 and LMV. The results will be proposed to the VAT lab to test the procedure on the electroporation on small animals and to evaluate the consistence of the optimization.
Coordinators of the consortium
Four local managers coordinate the consortium MEMOVE:
- Prof. François Buret at Ecole Centrale Lyon.
- Prof. Otared Kavian from Université de Versailles-Saint Quentin en Yvelines
- Dr Lluis M. Mir, senior researcher at the VAT lab of the CNRS.
- Dr Clair Poignard, confirmed researcher at EPI MC2 of INRIA Bordeaux.

